OKYO PHARMA LTD SP.ADR/65 (OK10) — Tangible Net Worth Ratio
OKYO PHARMA LTD SP.ADR/65 (OK10) has a Tangible Net Worth Ratio of 100.0% as of March 2022. This metric is calculated by deducting intangible assets (€0.00) from net assets (€2.95 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See OK10 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
OKYO PHARMA LTD SP.ADR/65 Tangible Net Worth Ratio (2022–2022)
This chart shows how OKYO PHARMA LTD SP.ADR/65's Tangible Net Worth Ratio has changed across 1 annual periods from 2022 to 2022. As of March 2022, the ratio stands at 100.0%, reflecting net assets of €2.95 Million with intangible assets of €0.00 EUR. Also explore OKYO PHARMA LTD SP.ADR/65 equity growth rate to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for OKYO PHARMA LTD SP.ADR/65 (2022–2022)
The table below presents the year-by-year Tangible Net Worth Ratio for OKYO PHARMA LTD SP.ADR/65 from 2022 to 2022, covering 1 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see OKYO PHARMA LTD SP.ADR/65 stock valuation.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 100.0% | €2.95 Million | €0.00 | €4.30 Million | — |